{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:54:54Z","timestamp":1791219294274,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Conjoined twins represent a rare condition in which drug exposure may be influenced by shared circulation and organ anatomy. For narrow therapeutic index antimicrobials such as amikacin, therapeutic drug monitoring (TDM) may require interpretation at twin-pair level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective TDM-informed coupled compartmental pharmacokinetic modeling study of 2 conjoined twin pairs was performed. One pair was pygopagus, and both twins (A and B) received amikacin treatment. The other pair was thoracopagus (X and Y) with complex shared cardiothoracic anatomy; amikacin was administered to twin X but not to twin Y. Data were reviewed and structured for pharmacokinetic modeling. Amikacin disposition was evaluated using a model incorporating twin-specific disposition and intertwin transfer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The pygopagus twins both received amikacin (35 mg) intravenously every 24 hours, corresponding to approximately 14.2 mg\/kg\/d. Paired concentrations showed asymmetric exposure despite identical nominal dosing: peak concentrations were 7.7 and 13.1 mg\/L, and trough concentrations were 4.0 and 2.7 mg\/L in twins A and B, respectively. Twin X received amikacin (85 mg; 15 mg\/kg\/d) intravenously every 24 hours during the first dosing period, followed by a single dose (83 mg) 3 days later. Approximately 69 hours after the last dose, the concentrations were 5.3\/L and 10.9 mg\/L in twin X and twin Y, respectively. A no-transfer model predicted no amikacin exposure in twin Y. Representative coupled solutions supported intertwin transfer in the 10\n                      <jats:sup>\u22122<\/jats:sup>\n                      L\/h range, and compatible Qtransfer values of approximately 0.016\u20130.066 L\/h were identified, indicating that no single transfer clearance value was uniquely identifiable from the 2 case 2 concentrations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This analysis illustrates how paired TDM and a literature-anchored coupled compartmental pharmacokinetic model can support drug exposure interpretation in exceptional clinical settings where conventional modeling is not feasible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001530","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:22Z","timestamp":1791216022000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Intertwin Amikacin Exposure in Conjoined Twins: A Therapeutic Drug Monitoring\u2013Informed Coupled Pharmacokinetic Modeling Case Study"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-3424","authenticated-orcid":false,"given":"H\u00fclya","family":"Tezel-Yal\u00e7\u0131n","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7583-389X","authenticated-orcid":false,"given":"\u0130rem","family":"\u0130yig\u00fcn","sequence":"additional","affiliation":[{"name":"Neonatology Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1725-0722","authenticated-orcid":false,"given":"Hasan Tolga","family":"\u00c7elik","sequence":"additional","affiliation":[{"name":"Neonatology Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-5105","authenticated-orcid":false,"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[{"name":"Department of Development and Regeneration, KU Leuven, Leuven, Belgium;"},{"name":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium;"},{"name":"Department of Clinical Pharmacy, Erasmus Medical Center, Rotterdam, the Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-8727","authenticated-orcid":false,"given":"Nadir","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"R1-20261005","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/ACO.0000000000000864","article-title":"Conjoined twins in 2020 - state of the art and future directions","volume":"33","author":"Frawley","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"key":"R2-20261005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.semperi.2018.07.009","article-title":"Pharmaceutical considerations with conjoined twins","volume":"42","author":"Rodman","year":"2018","journal-title":"Semin Perinatol"},{"issue":"6","key":"R3-20261005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.semperi.2018.07.012","article-title":"Nursing considerations and interdisciplinary coordination in the care of conjoined twins","volume":"42","author":"Luton","year":"2018","journal-title":"Semin Perinatol"},{"key":"R5-20261005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.semperi.2018.07.011","article-title":"Role of simulation in preparation for the care of conjoined twins-prenatal preparation to separation","volume":"42","author":"Parmekar","year":"2018","journal-title":"Semin Perinatol"},{"key":"R6-20261005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-2007-1000054","article-title":"Perinatal management of conjoined twins","volume":"1","author":"Herbert","year":"1983","journal-title":"Am J Perinatol"},{"key":"R7-20261005","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology--drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-20261005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/pan.12176","article-title":"Neonatal clinical pharmacology","volume":"24","author":"Allegaert","year":"2014","journal-title":"Paediatr Anaesth"},{"key":"R9-20261005","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0022-3468(88)80242-2","article-title":"Deterioration of renal function in a conjoined twin: lack of compensatory renal hypertrophy","volume":"23","author":"Snow","year":"1988","journal-title":"J Pediatr Surg"},{"key":"R10-20261005","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11095-013-1197-y","article-title":"A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates","volume":"31","author":"De Cock","year":"2014","journal-title":"Pharm Res"},{"key":"R11-20261005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11595640-000000000-00000","article-title":"Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance","volume":"51","author":"De Cock","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"R12-20261005","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1128\/AAC.46.5.1381-1387.2002","article-title":"Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children","volume":"46","author":"Treluyer","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-20261005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10928-013-9302-8","article-title":"Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian","volume":"40","author":"Tatarinova","year":"2013","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R14-20261005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jcph.1650","article-title":"Nonparametric methods in population pharmacokinetics","volume":"62","author":"Goutelle","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"R15-20261005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R","volume":"34","author":"Neely","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R16-20261005","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/AAC.01157-15","article-title":"Prospective evaluation of a model-based dosing regimen for amikacin in preterm and term neonates in clinical practice","volume":"59","author":"Smits","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-20261005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003088-200948020-00001","article-title":"Therapeutic drug monitoring of aminoglycosides in neonates","volume":"48","author":"Touw","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"R18-20261005","doi-asserted-by":"crossref","first-page":"624639","DOI":"10.3389\/fped.2021.624639","article-title":"Model-informed precision dosing of antibiotics in pediatric patients: a narrative review","volume":"9","author":"Abdulla","year":"2021","journal-title":"Front Pediatr"},{"key":"R19-20261005","first-page":"294","article-title":"Anaesthetic management of conjoined twins' separation surgery","volume":"53","author":"Chalam","year":"2009","journal-title":"Indian J Anaesth"},{"key":"R20-20261005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5152\/TJAR.2019.12316","article-title":"Anaesthesia management of premature conjoined twins with anal atresia","volume":"47","author":"Hatipoglu","year":"2019","journal-title":"Turkish J Anaesthesiol Reanimat"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:25Z","timestamp":1791216025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001530","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"2026-05-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}